ACCPL — Accretion Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.12bn
- IN₹1.26bn
- IN₹336.65m
- 21
- 21
- 73
- 29
Annual cashflow statement for Accretion Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 1.04 | 1.39 | 57.6 |
| Depreciation | |||
| Non-Cash Items | 10.2 | 10.8 | 11.5 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 2.19 | -18.2 | -90.9 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 21.5 | 3.21 | -13.3 |
| Capital Expenditures | -2.57 | -11.8 | -1.08 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 0.785 | 0 |
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -2.57 | -11 | -1.08 |
| Financing Cash Flow Items | -10.2 | -10.8 | -11.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -15.8 | 4.4 | 14.9 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3.08 | -3.38 | 0.553 |